Rocket Lab USA, Inc. (RKLB)
SubavaliadaFundamental
40
Preço
$71.24
Capitalização de Mercado
$47.07B
Parte 1 · Quanto vale a empresa
Visão Geral
Rocket Lab builds and launches rockets, and increasingly builds the satellites that fly on them. Its Electron rocket carries small satellites into orbit for government agencies and commercial operators who cannot fill a larger vehicle alone, and it is developing a bigger rocket, Neutron, aimed at the larger payloads that today mostly go to SpaceX. Alongside launch, its Space Systems division designs and manufactures satellite components and full spacecraft, a business it has grown mainly through acquisitions.
Como gera receita
Launch Services revenue is booked when Electron missions fly, priced per launch and per payload mass, so it depends on how many rockets get built and successfully flown in a given period. Space Systems revenue instead comes from selling hardware and engineering services under contracts that can run for months before a single item ships, so it recognizes revenue progressively as work is completed. Neutron has not yet flown commercially, so today's revenue is still almost entirely Electron launches and Space Systems contracts.
Receita por segmento
Design and manufacture of satellite components and complete spacecraft, built into a larger business mainly through acquisitions.
Electron rocket launches for government and commercial small-satellite customers, priced per mission and payload mass carried.
Vantagem competitiva
Patentes e licenças · EstreitaRocket Lab is one of very few companies anywhere that has repeatedly and reliably launched orbital rockets, a track record and set of government certifications that take years to earn and that most new entrants do not have. That edge is real in the small-launch niche, but SpaceX dominates the broader launch market by cost and cadence, and Neutron still has to prove itself before Rocket Lab can compete for larger payloads.
O que impulsiona a procura
Moderadamente cíclicoGovernment contracts, a large share of both segments, tend to be multi-year and relatively insulated from short-term economic swings, but they depend on national space and defense budgets that can shift with policy priorities. Commercial satellite demand is more cyclical, tied to how much capital satellite operators are able to raise and deploy at any given time.
Principais riscos
- Concentration in government funding — A large share of revenue across both segments ultimately depends on US government space and defense budgets, and a shift in agency priorities or a funding delay can slip contracts and revenue.
- Neutron development and execution risk — The larger Neutron rocket has not yet flown commercially and its timeline has already slipped; a further delay or a launch failure would set back Rocket Lab's ability to compete for bigger payloads.
- Launch failures and mission risk — A single launch failure can destroy a customer's payload, trigger contract penalties, and ground the launch schedule for months while the cause is investigated and fixed.
- Integration risk from rapid acquisitions — Space Systems has grown largely by acquiring other companies; folding their operations, contracts and engineering teams into Rocket Lab carries execution risk beyond organic growth.
Concentração de clientes
As of the end of 2024, Lockheed Martin and Dynetics each accounted for 15% of accounts receivable, and Rocket Lab's largest counterparty overall is the US government, whose funding decisions affect a large share of both segments.
Os argumentos a favor
Buyers argue that Rocket Lab's proven launch reliability and growing Space Systems business give it a rare, credible position as a full-stack space company beyond SpaceX, that Neutron opens a much larger addressable market once it flies, and that a fast-growing backlog shows real demand ahead of that capacity.
Os argumentos contra
Sellers fear that Neutron's delays push out the payoff for a company still spending heavily to develop it, that SpaceX's scale and pricing dominate the broader launch market Rocket Lab is trying to enter, and that heavy reliance on government budgets and a handful of large counterparties leaves results exposed to decisions Rocket Lab does not control.
Written by the editors, published on 18 de agosto de 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balanço & Liquidez
Receita
$769M
Últimos 12 meses (até 30/06/2026)
Resultado Líquido
$-165M
Últimos 12 meses (até 30/06/2026)
Fluxo de Caixa Livre
$-322M
Capital Próprio Total
$1.72B
Passivo Total
$603M
Rácio de Liquidez
5.48
Cobertura de Juros
8.64
Dívida/EBITDA
-
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$109.37
Preço Atual
$71.24
Margem de Segurança
+34.9%
Intervalo de Valor Justo
$103.90 - $114.84
Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
-
ROE
-11.5%
Rácio P/B
11.94
P/FCF
-
Margem Bruta
37.3%
ROIC
-4.8%
Radar de Rentabilidade
Criação de Valor (Vantagem Competitiva)
ROIC
-4.8%
WACC
18.0%
ROIC − WACC
-22.8 pp
O ROIC está abaixo do custo do capital — a empresa está a destruir valor a cada dólar investido.
Critérios de Análise Fundamental
Aprovado (11)
- EPS shows upward trend
- Price CAGR 38.17%
- Gross Margin 37.3%
- Debt/Equity ratio
- Current Ratio
- Interest Coverage
- Revenue Growth 5Y 76.5%
- Analyst Consensus 81% Buy
- Earnings Surprise avg 21.4%
- Net Margin Trend -21.5% vs -45.9%
- Piotroski F-Score 5/9
Reprovado (9)
- ROIC -4.8%
- P/B Ratio 11.94
- Operating Margin -29.1%
- Positive Free Cash Flow
- Return on Tangible Assets
- Low reliance on intangibles
- DCF valuation (Unknown)
- ROE -7.6%
- Share Dilution 7.0%
Indisponível (7)
- P/FCF NaN
- Dividend Payout NaN%
- CapEx intensity
- Debt/EBITDA
- Price below Graham Number
- PEG Ratio (need PE > 0 and growth > 0)
- Earnings Quality (OCF/Net Income)
Piotroski F-Score
Sinais mistos: algumas áreas requerem atenção
Qualidade dos Resultados
Baixa qualidade: investigar a contabilidade
Diluição de Ações
A emitir novas ações, diluindo a participação
Participações institucionais
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Sir Peter Beck | Founder, Chairman, President & CEO | 48 |
| Mr. Adam C. Spice | CFO & Treasurer | 56 |
| Mr. Frank Klein | Chief Operations Officer | 52 |
| Mr. Arjun L. Kampani J.D. | Senior VP, General Counsel & Corporate Secretary | 53 |
| Mr. Agostino Ricupati CPA | VP, Corporate Controller & Chief Accounting Officer | 58 |
| Ms. Morgan Bailey Connaughton | Vice President of Marketing & Communications | - |
| Ms. Connie Lundgren | Vice President of People & Culture | - |
| Mr. Shaun O'Donnell | Chief Engineer of Special Projects | 47 |
| Mr. Ehson Mosleh | Space Systems Chief Engineer | - |
| Mr. Marvin Bradford Clevenger Ph.D. | President of Rocket Lab USA Inc. | - |
Risco de Auditoria
7
Risco do Conselho
9
Risco de Remuneração
9
Risco dos Direitos dos Acionistas
8
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Documentos
- Ver documento
Relatório anual (10-K)
Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.
Arquivado em 2026-02-26
- Ver documento
Relatório trimestral (10-Q)
Uma atualização sobre o desempenho financeiro dos últimos três meses.
Arquivado em 2026-08-10
- Ver documento
Relatório de fato relevante (8-K)
Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.
Arquivado em 2026-09-15
via SEC EDGAR
Histórico de Resultados
via SEC EDGAR
Latest News
Recent headlines for RKLB, sourced from Markets Gazette.
- 1h agoPOSITIVERocket Lab in rialzo per contratto con Synspective: Citi vede +50%
Rocket Lab USA, Inc. experienced a stock surge exceeding 1% on Thursday following the announcement of its largest commercial launch contract to date. The multi-year agreement with Tokyo-based Synspective secures 20 additional Electron missions, bringing Synspective's total contracted launches to 47 and solidifying its position as Rocket Lab's largest customer. Complementing this, Citi initiated coverage with a 'Buy' rating and a $105 price target, suggesting a potential 50% upside from Wednesday's closing price. This news highlights Rocket Lab's growing dominance in the competitive satellite launch market and its strong customer relationships.
- 9d agoPOSITIVELe azioni Rocket Lab hanno creato un pattern rialzista: è il momento di comprare?
Rocket Lab USA, Inc. shares are showing a strong bullish pattern, having bounced from a recent low of $60 to trade just above it. The stock has formed a double-bottom pattern at the $60 mark, with a neckline resistance at $86.45. This technical setup, combined with investor buying on dips, suggests potential for a short-term continuation of the upward trend. The formation indicates a potential reversal from recent lows, signaling renewed investor interest and a possible upward trajectory for the stock.
- 22d agoNEUTRALAzioni Rocket Lab giù del 56% dal massimo annuale: opportunità d'acquisto?
Rocket Lab USA, Inc. shares have seen a significant decline, falling 56% from their annual high of $150 to the current $65. Despite this price drop, the company has achieved several key milestones, including new contracts with Space Force, Viasat, and MDA, and the release of its Inverted Metamorphic (IMM) Apex solar cell. Analysts suggest the current pullback might present a buying opportunity, potentially forming a double-bottom pattern. The underlying demand for Rocket Lab's space services remains strong, indicating potential for future recovery and growth.
- 29d agoPOSITIVECathie Wood acquista $31.6M di Rocket Lab: crede che la svendita sia esagerata?
ARK Investment Management, led by Cathie Wood, has significantly increased its stake in Rocket Lab USA, Inc. (NASDAQ: RKLB), acquiring approximately $31.6 million worth of shares on Tuesday, following a $44 million purchase over two days. This substantial buying activity from a prominent growth-focused fund manager comes despite recent stock price pressure and a narrowing launch window for Neutron, alongside a competitor securing a NASA contract. ARK's conviction suggests they believe the market's reaction to these events is an overreaction, presenting a potential buying opportunity for investors who share this long-term growth outlook for the space launch and satellite technology company.
- 8/18/2026POSITIVELe azioni Rocket Lab volano: un pattern raro indica rialzi, ma c’è un rischio
Rocket Lab USA, Inc. shares have surged from a low of $58.25 to $82, buoyed by strong earnings and an expanding backlog. The company's stock experienced a significant uplift following a major agreement with Viasat, a key player in satellite communications. Rocket Lab will provide its high-performance Lightning spacecraft platform for Viasat's payload. This development, coupled with a rare bullish double-bottom pattern formation, suggests further short-term upside potential for RKLB investors. The deal underscores Rocket Lab's growing influence in the space sector.
- 8/10/2026NEGATIVERocket Lab reveals some big plans, but its stock is dropping on mixed earnings
Rocket Lab USA, Inc. reported mixed financial results, leading to a stock price decline despite ambitious expansion plans. The company is focusing on extending its European presence and growing its order backlog, signaling potential future revenue streams. However, the immediate market reaction suggests that current earnings or forward guidance did not meet investor expectations, overshadowing the long-term strategic initiatives. Investors will be closely monitoring the execution of these expansion plans and their impact on profitability in upcoming quarters.
- 8/10/2026POSITIVERocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers
RocketLab USA Inc. saw its shares climb, continuing a positive trend from the previous Friday. This upward movement follows recent earnings reports from SpaceX, indicating a broader positive sentiment within the space industry. Investors are likely reacting to the competitive landscape and potential growth opportunities highlighted by these industry players. The renewed interest in space exploration and commercialization, coupled with SpaceX's performance, appears to be boosting investor confidence in RocketLab's prospects.
- 7/8/2026POSITIVERocket Lab’s stock could surge 250% as the company takes a page out of SpaceX’s book, analyst says
Morgan Stanley has upgraded its outlook on Rocket Lab USA, Inc., citing a significantly improved bull case driven by business diversification. The firm suggests the stock could experience a substantial surge of up to 250%. This optimistic projection is attributed to Rocket Lab adopting strategies similar to SpaceX, indicating a potential for accelerated growth and market expansion. Investors are watching closely as the company's strategic pivot aims to unlock new revenue streams and enhance its competitive position in the aerospace sector.
- 6/29/2026POSITIVERocket Lab to Buy Iridium in Challenge to SpaceX
Rocket Lab is set to acquire satellite communications firm Iridium Communications Inc. for $54 per share in a cash-and-stock deal, aiming to bolster its position in the orbital economy and challenge market leader SpaceX. The acquisition, valued at approximately $2.9 billion, will integrate Iridium's satellite constellation and services with Rocket Lab's launch capabilities. This strategic move is expected to enhance Rocket Lab's revenue streams and market competitiveness, potentially leading to increased investor interest and a re-evaluation of its growth prospects.
via Markets Gazette